TIANMU pharmaceutical industry by shareholders to reduce the cumulative excess of 1.9 million shares
Source: Internet
Author: User
NetEase Financial July 14 News Day Eye Pharmaceutical industry Wednesday evening Notice that the company received the company's shareholders on July 14 to reduce the share of the trade notice. The total reduction of 1.9009 million shares, accounting for the total number of shares of 1.56%. If the closing price of 14th calculated, reduce the amount of excess 23 million yuan. TIANMU pharmaceutical Industry said that the gold trade has 9,431,686 shares, accounting for the total number of shares of 7.74%. After the reduction, the gold trade still holds 7,530,786 shares of the company, accounting for 6.18% of the total shares of the company. As of 14th, the days of the Karma drug 12.19 yuan, rose 3.74%.
The content source of this page is from Internet, which doesn't represent Alibaba Cloud's opinion;
products and services mentioned on that page don't have any relationship with Alibaba Cloud. If the
content of the page makes you feel confusing, please write us an email, we will handle the problem
within 5 days after receiving your email.
If you find any instances of plagiarism from the community, please send an email to:
info-contact@alibabacloud.com
and provide relevant evidence. A staff member will contact you within 5 working days.
